Global Drug-Resistant Tuberculosis Treatment Market By Drug Class (Amoxicillin/Clavulanate, Bedaquiline, Carbapenems with Clavulanic Acid, Clofazimine, Other Drug Classes) By Disease Type (Active TB, Latent TB) By Treatment Type (First-Line Anti-TB Drugs, Second-Line Anti-TB Drugs) By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Feb 2024
- Report ID: 84849
- Number of Pages: 368
- Format:
-
-
-
- Sanofi SA
- Novartis AG Company Profile
- Endo International Plc
- CMP Pharma Inc.
- STI Pharma LLC
- Akorn Incorporated
- Lupin Ltd Company Profile
- Johnson & Johnson Services Inc.
- Macleods Pharmaceuticals Ltd.
- Pfizer Inc Company Profile
- Hikma Pharmaceuticals PLC
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible